Related Experiment Video

Updated: Jun 13, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Rab5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal

Zhen Zhao1, Xiang-Fan Liu, Hua-Cheng Wu

  • 1Department of Laboratory Medicine, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Cancer Science
|April 24, 2010
PubMed

Insights

Rab5a, a protein involved in cell signaling, is significantly elevated in ovarian cancer, promoting cancer cell growth and proliferation through the APPL1 pathway.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Rab5a is a GTPase regulating endocytic vesicle transport and intracellular signaling.
  • Aberrant Rab5a expression is linked to various cancers, including lung, stomach, and hepatocellular carcinomas.
  • Understanding Rab5a's role in ovarian cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression and function of Rab5a in ovarian cancer.
  • To elucidate the molecular mechanisms by which Rab5a influences ovarian cancer cell proliferation.
  • To explore the potential involvement of APPL1 in Rab5a-mediated ovarian cancer progression.

Main Methods:

  • Immunohistochemistry was used to detect Rab5a expression in ovarian cyst, benign cystadenoma, and ovarian cancer tissues.
  • Stable HO-8910 cell lines overexpressing Rab5a or a dominant-negative mutant (Rab5a:S34N) were established.
  • Laser scanning confocal microscopy was employed to visualize the colocalization of APPL1 and Rab5a.
  • Interactions between APPL1 and nuclear complexes like NuRD/MeCP1 were investigated.

Main Results:

  • Rab5a expression was significantly higher in ovarian cancer tissues compared to benign controls (P = 0.0001).
  • Rab5a overexpression enhanced HO-8910 cell proliferation by promoting cell cycle progression from G1 to S phase.
  • Dominant-negative Rab5a (Rab5a:S34N) inhibited this proliferative effect.
  • The downstream effector APPL1 also promoted cell cycle progression, an effect blocked by Rab5a:S34N.
  • APPL1 colocalized with Rab5a at the plasma membrane and translocated to the nucleus, interacting with NuRD/MeCP1.

Conclusions:

  • Rab5a overexpression significantly promotes ovarian cancer cell proliferation.
  • The APPL1-mediated signaling pathway, potentially involving epidermal growth factor signaling, is implicated in Rab5a's oncogenic function.
  • Rab5a represents a potential therapeutic target for ovarian cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...